KIORA PHARMACEUTICALS INC Balance Sheet
KPRX|8 years of annual SEC 10-K data (FY2016-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 8 fiscal years. All figures from audited SEC 10-K filings.
KIORA PHARMACEUTICALS INC had $24M in total assets and $26M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -5.41 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $8.7M | $3.8M | $1.2M | $1.2M | $3.8M | $8.0M | $7.8M | $8.4M |
| Accounts Receivable | $1.5M | $601.2K | - | - | - | - | - | - |
| Current Assets | $21.7M | $29.7M | $1.7M | $1.8M | $4.3M | $8.5M | $8.5M | $4.2M |
| PP&E (Net) | $91.7K | $5.2K | $30.6K | $30.6K | $16.8K | $43.5K | $55.8K | $38.0K |
| Goodwill | - | - | $3.5M | $3.5M | $1.5M | $1.5M | - | - |
| Total Assets | $24.3M | $36.5M | $15.2M | $15.2M | $10.1M | $14.3M | $14.3M | $9.7M |
| Current Liabilities | $3.6M | $6.0M | $1.8M | $1.8M | $1.4M | $3.9M | $14.8M | $7.3M |
| Total Debt | - | - | $278.2K | $278.2K | - | - | - | - |
| Shareholders' Equity | $25.8M | $6.1M | $6.6M | $6.6M | $8.9M | -$1.9M | -$1.9M | -$329.4K |